Ovid Therapeutics Inc
F:1OT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ovid Therapeutics Inc
F:1OT
|
US |
|
N
|
Nordic LEVEL Group AB
STO:LEVEL
|
SE |
|
N
|
Noram Drilling AS
XMUN:TM9
|
NO |
|
M
|
Mari Energies Ltd
KAR:MARI
|
PK |
|
P
|
Pakistan State Oil Company Ltd
KAR:PSO
|
PK |
|
M
|
Mattel Inc
XHAN:MTT
|
US |
|
G
|
Group 1 Automotive Inc
F:GAV
|
US |
|
P
|
Pernod Ricard SA
XHAN:PER
|
FR |
|
Edion Corp
F:9H2
|
JP |
|
O
|
Ovid Therapeutics Inc
SWB:1OT
|
US |
|
Ibex Ltd
F:IB7
|
US |
|
L
|
Lucky Cement Ltd
KAR:LUCK
|
PK |
|
Linedata Services SA
PAR:LIN
|
FR |
Wall St Price Targets
1OT Price Targets Summary
Ovid Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
1OT is 2.68 EUR with a low forecast of 1.93 EUR and a high forecast of 3.51 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 1OT's stock price target?
Price Target
2.68
EUR
According to Wall Street analysts, the average 1-year price target for
1OT is 2.68 EUR with a low forecast of 1.93 EUR and a high forecast of 3.51 EUR.
What is the Revenue forecast for Ovid Therapeutics Inc?
Projected CAGR
76%
The compound annual growth rate for Revenue over the next 8 years is 76%.